Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clarus Therapeutics
Northbrook, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Clarus Therapeutics developed JATENZO, an FDA-approved oral testosterone replacement therapy for men with hypogonadism. The product is a proprietary softgel capsule containing testosterone undecanoate formulated for intestinal lymphatic system absorption.
- Therapeutic areas
- Women's HealthEndocrinologyRare DiseasesNephrology
- Modalities
- Small molecule drugsChemical drugs
- Industry
- Biotech
02
Partnerships
Verity Pharmaceuticals, Inc.St. Louis UniversityUniversity of Miami
Beyond the preview
Go deeper on Clarus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clarus Therapeutics.